The case for universal Hepatitis B screening in China
The current screening program is limited to key target populations including pregnant women, newborn infants, and blood donors.
By
Diagnostics
Latest in
Diagnostics
Nearly 90% of overactive bladder cases go undiagnosed in major pharmaceutical markets
In the eight major pharmaceutical markets (8MM) (US, France, Germany, Italy, Spain, UK, Japan, and China), GlobalData epidemiologists found that…
By
Michael Thompson: Covid-19 lessons to optimise cancer clinical trial operations
Are there different investigator skillsets involved in running the varied stages of oncology trials?
By
Delayed diagnosis increases the burden of bipolar disorder
New research suggests long delays to bipolar disorder diagnosis, which may increase the burden the condition causes individuals.
By
In conversation: nonalcoholic steatohepatitis investigator Rohit Loomba
Top NASH investigator Rohit Loomba discusses the potential of imaging in replacing biopsies, and much more.
By
AI in healthcare: key highlights in 2021
As AI and machine learning continues to evolve, we look at how it has impacted healthcare in 2021.
By
New blood test could improve prostate cancer screening
A new novel blood test called the Stockholm3test could boost the prostate cancer screening process and help reduce cost and…
By
Promising therapeutics on horizon for recurrent and metastatic cervical cancer
Alternative treatment options for recurrent and metastatic cervical cancer can transform the landscape and satisfy unmet needs.
By